Kimer Med

Kimer Med is a dynamic biotechnology research company dedicated to advancing a robust pipeline of novel, broad-spectrum antiviral drug candidates. Focused on addressing the global health challenge of viral diseases and future pandemic threats, Kimer Med is committed to ending the immense suffering caused by viral infections.

With a vision to provide effective treatments for a wide range of viral diseases, Kimer Med has developed a proprietary platform for the rapid development of broad-spectrum antiviral drug candidates. To date, Kimer Med has achieved efficacy against 21 different viruses spanning 9 virus families, demonstrating the broad-spectrum capabilities of its innovative platform. Kimer Med's primary address is in Nelson, 7010, NZ.

Kimer Med is dedicated to bringing to market a family of broad-spectrum antivirals to treat multiple diseases and provide pandemic protection. The company is currently in the lead-optimization phase and nearing phase 1 clinical trials. We invite the management team at Kimer Med to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence and commercial development.